Calliditas Therapeutics A... (CALT)
NASDAQ: CALT
· Real-Time Price · USD
40.00
-0.04 (-0.10%)
At close: Sep 20, 2024, 10:00 PM
Calliditas Therapeutics AB (publ) Ratios and Metrics
Financials in SEK. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -57.9 | -3.09 | -94.68 | -7.95 | -12.46 | -8.9 | -319.96 | -61.45 | -3.13 | -2.84 | -3.34 | 93.65 | -4.91 | -5.99 |
PEG Ratio | 0.64 | -0.00 | 1.06 | -0.1 | 0.24 | -0.00 | 4.02 | 0.64 | 0.37 | 0.52 | 0.00 | -0.9 | -0.18 | 0.23 |
PS Ratio | 19.64 | 10.28 | 15.41 | 18.16 | 17.01 | 34.87 | 10.98 | 8.61 | 37.65 | 47.31 | 93.92 | 12.19 | n/a | n/a |
PB Ratio | 102.97 | 25.28 | 20.78 | 15.18 | 9.09 | 11.32 | 6.15 | 3.08 | 3.34 | 2.70 | 2.90 | 1.91 | 3.35 | 2.74 |
P/FCF Ratio | -1.56K | -15.33 | 691.69 | -85.57 | -28.11 | -28.77 | 20.71 | -17.95 | -10.71 | -12.29 | -17.45 | -72.67 | -23.63 | -22.38 |
P/OCF Ratio | -1.56K | -15.33 | 304.50 | -85.57 | -28.11 | -28.77 | 20.48 | -17.95 | -10.71 | -12.29 | -18.16 | -72.67 | -23.63 | -22.38 |
OCF/S Ratio | -0.01 | -0.67 | 0.05 | -0.21 | -0.61 | -1.21 | 0.54 | -0.48 | -3.52 | -3.85 | -5.17 | -0.17 | n/a | n/a |
Debt / Equity Ratio | 9.44 | 8.46 | 2.92 | 2.19 | 1.55 | 1.27 | 0.95 | 0.64 | 0.64 | 0.25 | 0.21 | 0.15 | 0.00 | 0.00 |
Quick Ratio | 2.59 | 2.62 | 3.08 | 2.96 | 3.77 | 3.89 | 4.33 | 4.42 | 5.32 | 5.36 | 7.47 | 8.97 | 6.26 | 8.09 |
Current Ratio | 2.69 | 2.69 | 3.13 | 3.01 | 3.84 | 3.93 | 4.34 | 4.42 | 5.32 | 5.37 | 7.48 | 8.97 | 6.03 | 7.75 |
Asset Turnover | 0.32 | 0.18 | 0.24 | 0.18 | 0.16 | 0.11 | 0.22 | 0.17 | 0.04 | 0.04 | 0.02 | 0.11 | n/a | n/a |
Interest Coverage | -3.06 | -4.69 | n/a | -35.39 | n/a | -6.59 | n/a | -1.79 | -11.82 | -69.92 | n/a | 5.71 | n/a | n/a |
Return on Equity | -0.44 | -2.05 | -0.05 | -0.48 | -0.18 | -0.32 | n/a | -0.01 | -0.27 | -0.24 | -0.22 | 0.01 | -0.17 | -0.11 |
Return on Assets | -0.03 | -0.15 | -0.01 | -0.1 | -0.05 | -0.1 | n/a | -0.01 | -0.13 | -0.15 | -0.15 | n/a | -0.13 | -0.09 |
Return on Invested Capital | -0.03 | -0.16 | 0.03 | -0.13 | -0.07 | -0.11 | -0.02 | -0.02 | -0.16 | -0.18 | -0.17 | n/a | -0.14 | -0.11 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.90 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.98 | 0.98 | 0.96 | 0.99 | 1.00 | 1.00 | n/a | n/a |
Net Profit Margin | -0.08 | -0.83 | -0.04 | -0.57 | -0.34 | -0.98 | -0.01 | -0.04 | -3 | -4.16 | -7.03 | 0.03 | n/a | n/a |
Pretax Profit Margin | -0.08 | -0.84 | -0.03 | -0.56 | -0.26 | -1.09 | 0.02 | -0.06 | -3 | -4.25 | -7.01 | 0.03 | n/a | n/a |
Operating Profit Margin | -0.06 | -0.69 | 0.07 | -0.54 | -0.28 | -0.96 | 0.18 | -0.14 | -3.28 | -4.31 | -7.12 | 0.04 | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -0.06 | -0.69 | 0.07 | -0.54 | -0.28 | -0.94 | 0.18 | -0.14 | -3.28 | -4.19 | -6.54 | 0.04 | n/a | n/a |